Citation Impact
Citing Papers
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
2012 Standout
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
Mucosal healing in inflammatory bowel diseases: a systematic review
2012 Standout
Systematic review: human gut dysbiosis induced by non‐antibiotic prescription medications
2017
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
2011 Standout
Amiodarone and the thyroid: a 2012 update.
2012
Comparison of prothrombin time (INR) results and main characteristics of patients on warfarin treatment in primary health care centers and anticoagulation clinics
2013 StandoutNobel
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
European evidence based consensus on the diagnosis and management of Crohn’s disease: current management
2006
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Quinolines and structurally related heterocycles as antimalarials
2010 Standout
Review article: monitoring of immunomodulators in inflammatory bowel disease
2005
Bleeding with anticoagulation therapy – Who is at risk, and how best to identify such patients
2009
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
2010 Standout
Chronic inflammation in the etiology of disease across the life span
2019 Standout
The Association between the Use of Proton Pump Inhibitors and the Risk of Hypomagnesemia: A Systematic Review and Meta-Analysis
2014
Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays
2010 StandoutNobel
The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics
2020 Standout
Perioperative Management of Antithrombotic Therapy
2012 Standout
Oral Anticoagulant Therapy
2012 Standout
Amiodarone and thyroid
2009
Daily vitamin K supplementation improves anticoagulant stability
2007
Antithrombotic Therapy for VTE Disease
2016 Standout
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Crohn's disease
2012 Standout
Emergency Hospitalizations for Adverse Drug Events in Older Americans
2011 Standout
The clinical implications of ageing for rational drug therapy
2008
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti‐FXa assays
2014 StandoutNobel
Role for TNF in atherosclerosis? Lessons from autoimmune disease
2009
Self-Management of Oral Anticoagulant Therapy: A Review
2004
Effects of amiodarone therapy on thyroid function
2009
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
CYP2C9 Genotype-guided Warfarin Prescribing Enhances the Efficacy and Safety of Anticoagulation: A Prospective Randomized Controlled Study
2007
Coumarins: Old Compounds with Novel Promising Therapeutic Perspectives
2010 Standout
Crohn's disease
2016 Standout
Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association
2019
VKORC1: molecular target of coumarins
2007
Enterochromaffin Cells Are Gut Chemosensors that Couple to Sensory Neural Pathways
2017 StandoutNobel
A genotyping method for VKORC1 1173C>T by Pyrosequencing®technology
2008 StandoutNobel
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
2010
Expression Profile of Ectopic Olfactory Receptors Determined by Deep Sequencing
2013
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
2008 Standout
Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: Prevention
2009
Systematic Overview of Warfarin and Its Drug and Food Interactions
2005 Standout
Atherosclerosis
2019 Standout
Appropriate Phenotyping Procedures for Drug Metabolizing Enzymes and Transporters in Humans and Their Simultaneous Use in the “Cocktail” Approach
2007
Primaquine revisited six decades after its discovery
2008
The Pharmacology and Management of the Vitamin K Antagonists
2004 Standout
Optimization of conventional therapy in patients with IBD
2011
A genome-wide association study of acenocoumarol maintenance dosage
2009
Influence of CYP2C9 and VKORC1 on warfarin response during initiation of therapy
2009
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Low‐Dose Vitamin K to Augment Anticoagulation Control
2005
Main haplotypes and mutational analysis of vitamin K epoxide reductase (VKORC1) in a Swedish population: a retrospective analysis of case records
2006 StandoutNobel
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Management of Crohn's Disease in Adults
2009 Standout
Mining electronic health records: towards better research applications and clinical care
2012 Standout
Genetic Determinants of Response to Warfarin during Initial Anticoagulation
2008
Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum
2011 Standout
2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis
2016 Standout
2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum
2017 Standout
Artificial intelligence in drug discovery and development
2020 Standout
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
Methotrexate for induction of remission in refractory Crohn's disease
2014
Influence of CYP2C9 and VKORC1 on Warfarin Dose, Anticoagulation Attainment and Maintenance Among European–Americans and African–Americans
2008
Referral of patients with thrombocytopenia from primary care clinicians to hematologists
2009
Guidelines for the Primary Prevention of Stroke
2014 Standout
Methotrexate for maintenance of remission in Crohn's disease
2014
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2010 Standout
Improved Oral Anticoagulation After a Dietary Vitamin K–Guided Strategy
2009
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
2009
Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease
2016 Standout
Drug delivery and nanoparticles: Applications and hazards
2008 Standout
Target identification among known drugs by deep learning from heterogeneous networks
2020
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Accuracy and clinical utility of a portable coagulometer in an emergency setting.
2011
Membrane transporter proteins: a challenge for CNS drug development
2006
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations
2009 Standout
Apixaban, an oral, direct factor X a inhibitor: single dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjects
2012
Vitamin K supplementation can improve stability of anticoagulation for patients with unexplained variability in response to warfarin
2006
Works of Daniel Kurnik being referenced
Over-the-counter vitamin K1-containing multivitamin supplements disrupt warfarin anticoagulation in vitamin K1-depleted patients
2004
Variations in the α2A-adrenergic receptor gene and their functional effects
2006
Muscle pain and serum creatine kinase are not associated with low serum 25(OH) vitamin D levels in patients receiving statins
2011
Differential in Vivo Sensitivity to Inhibition of P-glycoprotein Located in Lymphocytes, Testes, and the Blood-Brain Barrier
2006
Combined genetic profiles of components and regulators of the vitamin K-dependent γ-carboxylation system affect individual sensitivity to warfarin
2006
Common genetic variants of microsomal epoxide hydrolase affect warfarin dose requirements beyond the effect of cytochrome P450 2C9
2005
Bioavailability of oral vs. subcutaneous low‐dose methotrexate in patients with Crohn's disease
2003
Complex Drug-Drug-Disease Interactions Between Amiodarone, Warfarin, and the Thyroid Gland
2004
The erythromycin breath test reflects P-glycoprotein function independently of cytochrome P450 3A activity
2006
Short report: a consideration of primaquine dose adjustment for radical cure of Plasmodium vivax malaria.
2000
Potential dosing errors using portable prothrombin time monitoring devices
2003
Multivitamin Supplements May Affect Warfarin Anticoagulation in Susceptible Patients
2003
Change in mRNA Expression after Atenolol, a Beta‐adrenergic Receptor Antagonist and Association with Pharmacological Response
2009
Increased augmentation index in rheumatoid arthritis and its relationship to coronary artery atherosclerosis.
2007
Relative contribution of CYP2C9 and VKORC1 genotypes and early INR response to the prediction of warfarin sensitivity during initiation of therapy
2008
The association of proton pump inhibitors and hypomagnesemia in the community setting
2014